QCM : Understanding Diabetes: Types, Risks, and Management — 10 questions

Questions et réponses du QCM

1. What does diabetes mellitus primarily refer to?

A condition where blood sugar levels are always low
A chronic condition characterized by frequent infections
A metabolic disorder involving persistent high blood sugar levels due to insulin issues
A disease caused by autoimmune destruction of the pancreas only

A metabolic disorder involving persistent high blood sugar levels due to insulin issues

Explication

Diabetes mellitus is a metabolic disorder characterized by chronic hyperglycemia resulting from defects in insulin secretion, insulin action, or both, affecting carbohydrate, fat, and protein metabolism.

2. What is the fasting blood glucose level threshold that confirms diabetes according to the provided criteria?

Fasting blood glucose ≥1.10 g/l (6.1 mmol/l)
Fasting blood glucose ≥1.40 g/l (7.8 mmol/l)
Fasting blood glucose ≥1.26 g/l (7 mmol/l)
Fasting blood glucose ≥1.50 g/l (8.3 mmol/l)

Fasting blood glucose ≥1.26 g/l (7 mmol/l)

Explication

The diagnostic threshold for fasting blood glucose confirming diabetes is ≥1.26 g/l (7 mmol/l), as explicitly stated in the content. Values below this indicate normal or pre-diabetic levels, while levels at or above this confirm diabetes.

3. What is the primary role of studying Type 1 and Type 2 Diabetes in understanding human glucose regulation?

To prove that insulin is not involved in glucose metabolism
To show that diabetes is a normal part of aging
To illustrate that blood glucose levels are unaffected by insulin
To demonstrate how insulin deficiency leads to hyperglycemia

To demonstrate how insulin deficiency leads to hyperglycemia

Explication

Studying Type 1 and Type 2 Diabetes helps us understand how insulin deficiency (Type 1) and insulin resistance (Type 2) disrupt normal glucose regulation, leading to hyperglycemia, which highlights insulin's crucial role in maintaining blood glucose levels.

4. When was the initial WHO threshold of fasting blood glucose for diagnosing diabetes established?

The initial threshold was established at 1.26 g/l after 2010.
The initial threshold was established at 1.10 g/l before being revised to 1.26 g/l.
The initial threshold was established at 1.10 g/l in the early 2000s.
The initial threshold was established at 1.26 g/l in the late 1990s.

The initial threshold was established at 1.10 g/l before being revised to 1.26 g/l.

Explication

The initial WHO threshold for diagnosing diabetes was established at 1.10 g/l, but it was later revised to 1.26 g/l to improve diagnostic accuracy. The revision indicates the chronological order, with 1.10 g/l being the earlier established threshold.

5. How do microvascular and macrovascular complications of diabetes differ from each other?

Microvascular complications affect large blood vessels, leading to heart attacks and strokes, while macrovascular complications involve small vessels causing neuropathy and retinopathy.
Microvascular complications involve small blood vessels leading to neuropathy, retinopathy, and nephropathy, whereas macrovascular complications involve large vessels causing cardiovascular and cerebrovascular diseases.
Microvascular complications are caused by insulin deficiency, while macrovascular complications are caused by insulin resistance.
Both microvascular and macrovascular complications affect small blood vessels, but microvascular complications are more severe and cause organ failure.

Microvascular complications involve small blood vessels leading to neuropathy, retinopathy, and nephropathy, whereas macrovascular complications involve large vessels causing cardiovascular and cerebrovascular diseases.

Explication

Microvascular complications involve small blood vessels, leading to neuropathy, retinopathy, and nephropathy, while macrovascular complications involve large blood vessels, causing cardiovascular, cerebrovascular, and peripheral arterial diseases. They differ mainly in the size of affected vessels and clinical manifestations, although both are related to chronic hyperglycemia.

6. Who is credited with discovering insulin?

Alexander Fleming
Frederick Banting
Louis Pasteur
Robert Koch

Frederick Banting

Explication

Frederick Banting, along with Charles Best, is credited with discovering insulin in 1921, which revolutionized the treatment of diabetes. Louis Pasteur was known for microbiology and vaccines, Robert Koch for microbiology and germ theory, and Alexander Fleming for discovering penicillin. None of these are associated with insulin discovery.

7. What is a primary consequence of chronic hyperglycemia in diabetes management?

It results in immediate hypoglycemia episodes
It enhances insulin sensitivity in tissues
It causes autoimmune destruction of pancreatic beta cells
It leads to macrovascular and microvascular complications

It leads to macrovascular and microvascular complications

Explication

Chronic hyperglycemia causes vascular damage, leading to macrovascular complications like cardiovascular disease and microvascular complications such as retinopathy, nephropathy, and neuropathy. These are major causes of morbidity and mortality in diabetes.

8. How should insulin doses be adjusted in practice to achieve optimal glycemic control?

Adjust doses randomly to see what works best
Use a fixed insulin dose regardless of blood glucose levels
Titrate insulin doses based on blood glucose measurements, including fasting and postprandial levels
Only adjust insulin doses during hospital visits without monitoring blood glucose regularly

Titrate insulin doses based on blood glucose measurements, including fasting and postprandial levels

Explication

The correct approach is to titrate insulin doses based on blood glucose measurements, including fasting and postprandial levels, to achieve personalized glycemic targets. This practice ensures effective management and minimizes risks of hypo- or hyperglycemia. Random adjustments, fixed doses without monitoring, or adjusting only during hospital visits are not appropriate practices for insulin management.

9. Which of the following best describes the key glycemic control targets for managing diabetes?

Fasting blood glucose below 0.80 g/l and postprandial glucose below 1.40 g/l
Fasting blood glucose between 1.10 and 1.25 g/l and postprandial glucose between 1.40 and 1.99 g/l
Fasting blood glucose below 1.50 g/l and postprandial glucose below 2.50 g/l
Fasting blood glucose below 1.10 g/l and postprandial glucose below 2 g/l

Fasting blood glucose between 1.10 and 1.25 g/l and postprandial glucose between 1.40 and 1.99 g/l

Explication

The key features of glycemic control goals include specific thresholds for fasting blood glucose and postprandial glucose levels. The most accepted targets are fasting glucose between 1.10 and 1.25 g/l (6.1–6.9 mmol/l) and postprandial levels between 1.40 and 1.99 g/l (7.8–11 mmol/l), which help guide therapy and assess control. The other options either set thresholds too low, too high, or are not aligned with clinical guidelines.

10. What does 'Diabetes in Elderly' refer to?

A rare genetic disorder affecting insulin production, usually diagnosed in infancy.
A condition with increased prevalence among older adults, involving specific management challenges and impact on aging processes.
A metabolic disorder with insulin resistance, primarily developing in middle-aged adults with obesity.
A chronic disease characterized by autoimmune destruction of pancreatic beta cells, mainly affecting young individuals.

A condition with increased prevalence among older adults, involving specific management challenges and impact on aging processes.

Explication

'Diabetes in Elderly' refers to the increased prevalence of diabetes among older populations, with unique management challenges and effects on aging. It is characterized by a higher incidence of comorbidities, polypharmacy, and altered physiological responses, requiring tailored treatment approaches, unlike the other options which describe different types or aspects of diabetes not specific to the elderly.

Révisez avec les flashcards

Mémorisez les réponses avec 20 flashcards sur Understanding Diabetes: Types, Risks, and Management.

Diabetes — definition?

Chronic hyperglycemia from insulin issues.

Blood glucose — normal range?

Less than 1.10 g/l fasting.

Type 1 vs 2 — difference?

Type 1: autoimmune, insulin deficiency; Type 2: resistance, insulin decline.

Voir les flashcards →

Approfondir avec la fiche

Consultez la fiche de révision complète sur Understanding Diabetes: Types, Risks, and Management.

Voir la fiche →

Cours similaires

Physiologie rénale

Physiologie

Prothèse adjointe et assistance clinique

Anatomie

Anatomie et physiologie des appareils

Anatomie

Fiches de révision PSE1

Physiologie du tissu nerveux

Physiologie

Organisation du système nerveux

Anatomie

Crée tes propres QCM

Importe ton cours et l'IA génère des QCM avec corrections en 30 secondes.

Générateur de QCM